Tamoxifen in advanced prostate cancer: An ECOG pilot study
Authors:
- 1 January 1988
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 12 (2) , 173-177
Abstract
A group of 19 patients with advanced (Stage D) prostate cancer were treated with one of three dose levels of the anti‐estrogen tamoxifen, 10 mg (3 patients), 20 mg (8 patients), or 30 mg (8 patients) daily. Five patients had received no prior systemic therapy. The treatment was tolerated well, but no objective responses occurred.Keywords
This publication has 1 reference indexed in Scilit: